Ra Capital Management, L.P. Cytek Biosciences, Inc. Transaction History

Ra Capital Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	BUY	$5.52 - $9.5 $37.6 Million - $64.7 Million	6,809,404 New	6,809,404 $37.6 Billion
Q2 2023 Aug 14, 2023	SELL	$6.69 - $11.99 $7.25 Million - $13 Million	-1,083,333 Reduced 8.1%	12,297,721 $105 Million
Q1 2022 May 16, 2022	BUY	$9.89 - $17.25 $37.3 Million - $65.1 Million	3,774,026 Added 39.28%	13,381,054 $144 Million
Q3 2021 Nov 15, 2021	BUY	$17.52 - $27.93 $168 Million - $268 Million	9,607,028 New	9,607,028 $206 Million

134

71.7M

400

Ticker CTKB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 134,627,008
Market Cap $874M
Description
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ra Capital Management, L.P. with notifications on news.